[Ethambutol in combined chemotherapy of pulmonary tuberculosis]. 1970

J Kisielewicz, and W Dobrzyński, and B Fafrowicz, and I Kociecka, and J Szmygin, and R Turczynowski

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D004977 Ethambutol An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. (From Smith and Reynard, Textbook of Pharmacology, 1992, p863) Dexambutol,EMB-Fatol,EMB-Hefa,Etambutol Llorente,Ethambutol Hydrochloride,Etibi,Miambutol,Myambutol,EMB Fatol,EMB Hefa,Hydrochloride, Ethambutol,Llorente, Etambutol
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

J Kisielewicz, and W Dobrzyński, and B Fafrowicz, and I Kociecka, and J Szmygin, and R Turczynowski
January 1973, The Indian journal of chest diseases,
J Kisielewicz, and W Dobrzyński, and B Fafrowicz, and I Kociecka, and J Szmygin, and R Turczynowski
October 1978, Problemy tuberkuleza,
J Kisielewicz, and W Dobrzyński, and B Fafrowicz, and I Kociecka, and J Szmygin, and R Turczynowski
January 1951, Zeitschrift fur Tuberkulose,
J Kisielewicz, and W Dobrzyński, and B Fafrowicz, and I Kociecka, and J Szmygin, and R Turczynowski
June 1969, El Torax,
J Kisielewicz, and W Dobrzyński, and B Fafrowicz, and I Kociecka, and J Szmygin, and R Turczynowski
December 1954, Der Tuberkulosearzt,
J Kisielewicz, and W Dobrzyński, and B Fafrowicz, and I Kociecka, and J Szmygin, and R Turczynowski
January 1969, Acta tuberculosea et pneumologica Belgica,
J Kisielewicz, and W Dobrzyński, and B Fafrowicz, and I Kociecka, and J Szmygin, and R Turczynowski
February 1973, Vrachebnoe delo,
J Kisielewicz, and W Dobrzyński, and B Fafrowicz, and I Kociecka, and J Szmygin, and R Turczynowski
September 1970, Deutsche medizinische Wochenschrift (1946),
J Kisielewicz, and W Dobrzyński, and B Fafrowicz, and I Kociecka, and J Szmygin, and R Turczynowski
January 1969, Beitrage zur Klinik und Erforschung der Tuberkulose und der Lungenkrankheiten,
J Kisielewicz, and W Dobrzyński, and B Fafrowicz, and I Kociecka, and J Szmygin, and R Turczynowski
June 1967, Naika. Internal medicine,
Copied contents to your clipboard!